Inoue T - Search Results

1

Associations between cognitive impairment and illness awareness in fully remitted bipolar outpatients.

Toyoshima K, Kako Y, Toyomaki A, Shimizu Y, Tanaka T, Nakagawa S, Inoue T, Martinez-Aran A, Vieta E, Kusumi I. Toyoshima K, et al. Among authors: inoue t. Psychiatry Res. 2021 Feb;296:113655. doi: 10.1016/j.psychres.2020.113655. Epub 2020 Dec 18. Psychiatry Res. 2021. PMID: 33373809

2

Serotonin transporters.

Inoue T, Kusumi I, Yoshioka M. Inoue T, et al. Curr Drug Targets CNS Neurol Disord. 2002 Oct;1(5):519-29. doi: 10.2174/1568007023338987. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769604 Review.

3

Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats.

Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T. Kitaichi Y, et al. Among authors: inoue t. Eur J Pharmacol. 2004 Apr 12;489(3):187-91. doi: 10.1016/j.ejphar.2004.02.039. Eur J Pharmacol. 2004. PMID: 15087241

4

Single footshock attenuates c-Fos expression induced by 5-HT2A receptor agonist (+/-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride in rat brain.

Izumi T, Kitaichi Y, Nakagawa S, Inoue T, Koyama T. Izumi T, et al. Among authors: inoue t. Brain Res. 2004 Jun 11;1011(1):129-34. doi: 10.1016/j.brainres.2004.02.071. Brain Res. 2004. PMID: 15140652

5

Effect of mediodorsal thalamic nucleus lesion on contextual fear conditioning in rats.

Li XB, Inoue T, Nakagawa S, Koyama T. Li XB, et al. Among authors: inoue t. Brain Res. 2004 May 22;1008(2):261-72. doi: 10.1016/j.brainres.2004.02.038. Brain Res. 2004. PMID: 15145764

6

[Biological basis of anxiety disorders and serotonergic anxiolytics].

Inoue T, Izumi T, Li XB, Huang JZ, Kitaichi Y, Nakagawa S, Koyama T. Inoue T, et al. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Jun;24(3):125-31. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004. PMID: 15291241 Review. Japanese.

7

Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala.

Inoue T, Li XB, Abekawa T, Kitaichi Y, Izumi T, Nakagawa S, Koyama T. Inoue T, et al. Eur J Pharmacol. 2004 Aug 30;497(3):311-6. doi: 10.1016/j.ejphar.2004.06.061. Eur J Pharmacol. 2004. PMID: 15336949

8

Olanzapine increases plasma ghrelin level in patients with schizophrenia.

Murashita M, Kusumi I, Inoue T, Takahashi Y, Hosoda H, Kangawa K, Koyama T. Murashita M, et al. Among authors: inoue t. Psychoneuroendocrinology. 2005 Jan;30(1):106-10. doi: 10.1016/j.psyneuen.2004.05.008. Psychoneuroendocrinology. 2005. PMID: 15358448 Clinical Trial.

9

Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.

Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T. Kitaichi Y, et al. Among authors: inoue t. Eur J Pharmacol. 2005 Jun 15;516(3):219-26. doi: 10.1016/j.ejphar.2005.04.038. Eur J Pharmacol. 2005. PMID: 15963494

10

Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.

Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M. Kunugi H, et al. Among authors: inoue y, inoue t. Neuropsychopharmacology. 2006 Jan;31(1):212-20. doi: 10.1038/sj.npp.1300868. Neuropsychopharmacology. 2006. PMID: 16123748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,859 results

Search Page

Filters